1. Home
  2. AMBA vs HAE Comparison

AMBA vs HAE Comparison

Compare AMBA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$71.37

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$80.28

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
HAE
Founded
2004
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
AMBA
HAE
Price
$71.37
$80.28
Analyst Decision
Strong Buy
Buy
Analyst Count
9
9
Target Price
$97.25
$88.38
AVG Volume (30 Days)
844.3K
750.1K
Earning Date
11-25-2025
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.54
EPS
N/A
3.44
Revenue
$373,850,000.00
$1,327,850,000.00
Revenue This Year
$39.65
N/A
Revenue Next Year
$9.86
$6.01
P/E Ratio
N/A
$23.37
Revenue Growth
48.08
N/A
52 Week Low
$38.86
$47.32
52 Week High
$96.69
$87.32

Technical Indicators

Market Signals
Indicator
AMBA
HAE
Relative Strength Index (RSI) 40.69 58.03
Support Level $69.62 $79.20
Resistance Level $74.58 $80.94
Average True Range (ATR) 2.78 2.08
MACD 0.08 -1.19
Stochastic Oscillator 18.68 17.48

Price Performance

Historical Comparison
AMBA
HAE

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: